COA6 facilitates cytochrome c oxidase biogenesis as thiol-reductase for copper metallochaperones in mitochondria. by Pacheu-Grau, D. et al.
Journal Pre-proof
COA6 facilitates cytochrome c oxidase biogenesis as thiol-reductase for copper
metallochaperones in mitochondria
David Pacheu-Grau, Michał Wasilewski, Silke Oeljeklaus, Christine Silvia Gibhardt,
Abhishek Aich, Margarita Chudenkova, Sven Dennerlein, Markus Deckers, Ivan




To appear in: Journal of Molecular Biology
Received Date: 5 November 2019
Revised Date: 23 January 2020
Accepted Date: 27 January 2020
Please cite this article as: D. Pacheu-Grau, M. Wasilewski, S. Oeljeklaus, C.S. Gibhardt, A. Aich,
M. Chudenkova, S. Dennerlein, M. Deckers, I. Bogeski, B. Warscheid, A. Chacinska, P. Rehling,
COA6 facilitates cytochrome c oxidase biogenesis as thiol-reductase for copper metallochaperones in
mitochondria, Journal of Molecular Biology, https://doi.org/10.1016/j.jmb.2020.01.036.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2020 Published by Elsevier Ltd.
Credit Author Statement 
 
David Pacheu-Grau. Conceptualization, methodology, investigation, visualization, writing-
original draft and supervision. Michał Wasilewski. Methodology, investigation, visualization, 
and writing-review/editing. Silke Oeljeklaus. Investigation, visualization and writing-
review/editing. Christine Silvia Gibhardt. Investigation and writing-review/editing. Abhishek 
Aich. Investigation.  Sven Dennerlein. Investigation and visualization. Margarita 
Chudenkova. Investigation. Markus Deckers. Investigation and visualization. Ivan Bogeski. 
Resources, writing-review/editing and funding acquisition. Bettina Warscheid. Resources, 
writing-review/editing and funding acquisition. Agnieszka Chacinska. Conceptualization, 
resources, writing-review/editing and funding acquisition. Peter Rehling. Conceptualization, 





S S S S
COX2
SH SH SH SH
  1
COA6 facilitates cytochrome c oxidase biogenesis as thiol-reductase for 
copper metallochaperones in mitochondria 
 
David Pacheu-Grau1,#, Michał Wasilewski2,3, Silke Oeljeklaus4,5, Christine Silvia 
Gibhardt6, Abhishek Aich1, Margarita Chudenkova1 Sven Dennerlein1, Markus 
Deckers1, Ivan Bogeski,6, Bettina Warscheid4,5, Agnieszka Chacinska2,3, & Peter 
Rehling1,7,# 
 
1Department of Cellular Biochemistry, University Medical Center Göttingen, D-37073 
Göttingen, Germany. 
2
 Laboratory of Mitochondrial Biogenesis, Centre of New Technologies, University of 
Warsaw, Warsaw, Poland. 
3 ReMedy International Research Agenda Unit, Centre of New Technologies, 
University of Warsaw, Poland. 
4 Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology.  
5 Signalling Research Centres BIOSS and CIBSS, University of Freiburg, D-79104 
Freiburg, Germany.  
6
 Molecular Physiology, Institute of Cardiovascular Physiology, University Medical 
Center, Georg-August-University, Göttingen, Germany. 
7
 Max-Planck Institute for Biophysical Chemistry, D-37077, Göttingen, Germany. 
 
# Correspondence: Peter Rehling, Department of Cellular Biochemistry, University 
Medical Center Göttingen, Humboldtallee 23, 37073 Göttingen, Germany.  
Fax: +49 551 395979;  
Tel: +49 551 395947;  
Email: peter.rehling@medizin.uni-goettingen.de 
 
David Pacheu-Grau, Department of Cellular Biochemistry, University Medical Center 
Göttingen, Humboldtallee 23, 37073 Göttingen, Germany.  
Fax: +49 551 395979;  





The mitochondrial cytochrome c oxidase, the terminal enzyme of the respiratory 
chain, contains heme and copper centers for electron transfer. The conserved COX2 
subunit contains the CuA site, a binuclear copper center. The copper chaperones 
SCO1, SCO2, and COA6 are required for CuA center formation. Loss of function of 
these chaperones and the concomitant cytochrome c oxidase deficiency cause 
severe human disorders. Here we analyzed the molecular function of COA6 and the 
consequences of COA6 deficiency for mitochondria. Our analyses show that loss of 
COA6 causes combined complex I and complex IV deficiency and impacts 
membrane potential driven protein transport across the inner membrane. We 
demonstrate that COA6 acts as a thiol-reductase to reduce disulphide bridges of 
critical cysteine residues in SCO1 and SCO2. Cysteines within the CX3CXNH domain 
of SCO2 mediate its interaction with COA6 but are dispensable for SCO2-SCO1 

















Mitochondria fulfil central functions in eukaryotic metabolism. In addition to 
participating in metabolite turnover and synthesis, mitochondria supply cells with the 
bulk of energy to drive cellular processes. At the heart of this process is the oxidative 
phosphorylation system (OXPHOS), which is located in the inner mitochondrial 
membrane.  The protein complexes of the OXPHOS system derive from subunits of 
dual genetic origin. Thirteen subunits are encoded on human mitochondrial DNA 
(mtDNA), whereas the rest of the components are encoded in the nucleus, 
synthesized on cytosolic ribosomes, and transported into mitochondria [1,2]. Hence, 
biogenesis of respiratory chain complexes and the F1Fo ATP synthase requires 
assembly of proteins that reach the inner membrane through different supply routes 
[3,4]. In addition, during the assembly process the redox-active cofactors need to be 
integrated. The cytochrome c oxidase (complex IV) contains two heme cofactors (a 
and a3) and two copper centers (CuA and CuB), required for reduction of molecular 
oxygen to water.  
 COA6 represents a conserved complex IV assembly factor required for the 
metalation of the COX2 subunit, which is critical for the formation of the CuA center in 
the intermembrane space domain [5-10]. Loss of COA6 function is associated with 
hypertrophic cardiomyopathy and loss of either complex I and IV [11] or isolated 
complex IV deficiency [12]. COA6 was found in a complex with the 
metallochaperones SCO1 and SCO2, which are required for copper insertion into the 
CuA center [7,8] (Fig 1A). SCO1 and SCO2 have distinct but cooperative functions in 
copper delivery to the CuA. While SCO2 is thought to deliver the copper molecule to 
COX2, SCO1 facilitates copper transfer to SCO2 from COX17 [13,14]. In addition, 
SCO2 is considered to regulate the thiol redox or metalation state of SCO1, thereby 
fulfilling a signalling role to regulate cellular copper efflux [15]. In contrast, recent in 
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vitro studies suggested that copper transfer to the CuA site only requires SCO1, while 
SCO2 regulates the thiol redox state of COX2 but not of SCO1 [16]. Since cofactor 
insertion into the CuA center is thought to be coupled to COX2 insertion into the 
membrane, SCO1 and SCO2 have been found to interact with FAM36A [17] . In 
addition SCO1, SCO2 and COA6 have been found to interact with COX16, a factor 
involved in delivering COX2 after metalation to the complex IV assembly 
intermediates (MITRAC complexes) [18]. A structural analysis of Coa6, revealed that 
the four Cys of the CX9C-CX10C motive form disulphide bridges. Based on the 
observation, that the Cys58-Cys90 disulphide bridge could be chemically reduced to 
free thiol groups, has been taken as indication that these residues could be required 
for copper coordination [19]. However, the molecular function of COA6 in copper 
insertion into the CuA center and the question as to how the structural determinants 
of the protein relate to its molecular function remain unaddressed. 
 Here, we generated a COA6 knock out HEK 293T cell line to analyze COA6 
function in CuA-site formation. Loss of COA6 function led to combined complex I and 
complex IV deficiency. A concomitant reduction of the inner membrane potential (∆Ψ) 
caused defects in membrane potential driven protein transport across the inner 
mitochondrial membrane, whereas the Mitochondrial intermembrane space import 
and assembly protein 40 (MIA40/ CHCHD4)-dependent import into the 
intermembrane space was not compromised. Our analyses demonstrated that COA6 
acts as a thiol-reductase to reduce disulphide bridges in the metallochaperones 
SCO1 and SCO2. The cysteines of the thioredoxin-like fold of SCO2 are required for 
the interaction with COA6 but dispensable for the dynamic interaction between SCO1 
and SCO2. We conclude that the thiol reduction activity of COA6 is necessary for 







Lack of COA6 affects complex I and complex IV  
COA6 participates in copper insertion into COX2 through interactions with the copper 
chaperones SCO1 and SCO2 and the assembly factors COX18 and COX16 
([7,8,10,18]. However, the mechanism of copper transfer to COX2 and the role of 
COA6 in this process are ill defined. To understand COA6 function in this process, 
we generated a COA6 knock out HEK 293T cell line (COA6KO) using the 
CRISPR/Cas9 system. Sequencing analyses revealed a deletion in Exon 2 that 
generates a premature Stop codon in the COA6 gene (Fig. Sup1A). The COA6KO 
displayed a strongly reduced growth rate compared to the wild type. Introduction of a 
FLAG-tagged COA6 version into the knock out partially restored cellular growth (Fig. 
1B). Since patients carrying COA6 mutations displayed fatal hypertrophic 
cardiomyopathy and presented in one case with combined complex I and complex IV 
[11] and in another case with isolated complex IV deficiency [12], we assessed 
respiratory chain function in the mutant cells. Therefore, we measured oxygen 
consumption by real time respirometry in intact cells. Respiration of COA6 knock out 
cells was drastically reduced compared to the wild type in agreement with a defect of 
oxidative phosphorylation (Fig. 1C). To define how loss of COA6 affected the 
different complexes of the respiratory chain, we measured the activity and amounts 
of the cytochrome c oxidase. Complex IV activity and amount were drastically 
reduced in COA6 knock out cells as expected. Expression of a FLAG-tagged COA6 
largely restored this defect (Fig. 1D and E) and in Western blot analyses was also 
found to rescue steady state proteins levels of complex IV components (Fig. Sup1B). 
We previously showed that silencing of COA6 by siRNA treatment also led to 
reduced activity and amounts of complex I [7]. In contrast, Stroud et al. reported that 
the loss of COA6 led to selective  complex IV deficiency [8]. Therefore, we 
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investigated if complex I was affected in COA6KO cells. To this end, we determined 
the enzymatic activity of complex I in a colorimetric assay. Interestingly, compared to 
wild type, the activity of complex I was strongly decreased in COA6KO cells (Fig. 1F). 
Under certain conditions, defects in oxidative phosphorylation can cause production 
of reactive oxygen species (ROS)[20] and thus affect the mitochondrial glutathione 
redox potential. To address this, we measured superoxide production in wild type 
and COA6KO cells using the fluorescent dye MitoSOX. As depicted in (Fig. 1G) we 
found a decrease in superoxide levels in the absence of COA6. In addition, we 
analyzed the general redox buffering capacity of mitochondria by measuring 
glutathione redox potential using the Grx1-roGFP2 sensor targeted to the 
intermembrane space (IMS) or the mitochondrial matrix. These fluorescent sensors 
monitor the glutathione redox potential that is affected by ROS [21]. These analyses 
showed no differences of the redox potential between wild type and COA6KO cells 
(Fig. 1H). Accordingly, loss of COA6 leads to a combined complex IV and complex I 
deficiency in mitochondria. However, an increase in ROS production was not 
apparent in mutant cells nor did we detect alterations in the mitochondrial glutathione 
redox potential. 
 
Lack of COA6 impacts protein import 
To address to which extent the different components of complexes I and IV were 
altered in the absence of COA6 and if other mitochondrial proteins were also 
affected, we assessed changes in the proteome of mitochondria isolated from 
wildtype and COA6-deficient cells by quantitative mass spectrometry. Interestingly, 
the mitochondrial-encoded core components of cytochrome c oxidase COX1, COX2, 
and COX3 were strongly decreased in COA6KO mitochondria. In addition, other 
structural components of complex IV and of complex I were decreased in 
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mitochondria in the absence of COA6. In contrast, constituents of complex V were 
not significantly affected (Fig. 2A). These results were confirmed using SDS-PAGE 
and Western blotting (Fig. 2B). However, to our surprise, many other mitochondrial 
proteins not related to the OXPHOS system were decreased in COA6KO 
mitochondria. We reasoned that a reduced activity of the respiratory chain would 
impact the transfer of protons to the intermembrane space and thereby affect the 
mitochondrial inner membrane potential, which drives protein import into 
mitochondria. To this end, we measured the membrane potential by flow cytometry. 
COA6KO cells indeed displayed a strongly reduced membrane potential (Fig. 2C). 
Accordingly, it is conceivable that the loss of complexes I and IV and the resulting 
decrease of the inner membrane potential reduced the import capacity of 
mitochondria leading to alterations in protein abundance. Therefore, we imported 
radiolabeled precursor proteins that follow different import routes into purified 
COA6KO mitochondria. The presequence-containing precursors OTC (ornithine-
transcarbamylase) and Su9-DHR (subunit 9 of the F1Fo ATP synthase) are 
transported by the TIM23 complex in a membrane potential-dependent manner into 
the mitochondrial matrix. Compared to wild type mitochondria, the import of both 
precursor proteins was reduced in the absence of COA6 (Fig. 2D and E). Metabolite 
carriers are imported and inserted into the inner mitochondrial membrane by the 
TIM22 complex in a membrane potential dependent manner. We performed in vitro 
import analyses of the model carrier transport pathway substrate ANT3 (ADP/ATP 
carrier 3) and SLC25A19 (thiamine pyrophosphate carrier). After import, 
mitochondria were solubilized and imported proteins analyzed by Blue Native PAGE 
(BN-PAGE). In both cases, we observed a strongly decreased import in COA6KO 
mitochondria (Fig. 2F and G). In contrast to presequence-containing precursors and 
carriers, mitochondrial proteins of the intermembrane space that contain twin CXNC 
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motifs, which are oxidized upon import forming disulphide bridges with the assistance 
of MIA40, are imported independent of a membrane potential. Hence, we analyzed 
the import efficiency of the MIA40 substrates COX6B1 and COX19 in the absence of 
COA6. Interestingly, import of precursors into the intermembrane space along the 
MIA40 pathway was not impaired in the absence of COA6 but rather accelerated 
(Fig. 2H and I). In summary, in the absence of COA6, the import routes that depend 
on the inner membrane potential are affected. However, the membrane potential 
independent import into the intermembrane space via MIA40 was not reduced but 
rather stimulated. Hence, a loss of membrane potential due to loss of complexes I 
and IV causes pleiotropic defects via compromised import of proteins that translocate 
across the inner membrane. 
 
Cysteines in the CXXXC motif of SCO2 are required for binding to COA6 
COA6 cooperates with SCO1 and SCO2 in the metalation of COX2 [7,8]. Mimicking 
pathologic mutations in either COA6 or SCO2 affected co immunoisolation of these 
proteins [7]. To address if SCO2 and COA6 directly interacted with each other, we 
incubated COA6FLAG containing mitochondria with the sulfhydryl reactive crosslinker 
BMH. After FLAG immunoisolation, COA6-SCO2 crosslinks were recovered in the 
eluate, indicating that both proteins were covalently linked via crosslinking of cysteine 
residues (Fig 3A).  
SCO1 and SCO2 contain a CX3CXnH motif that allows them either to bind 
Cu(I) with high affinity or to act as thiol-oxidoreductases [22,23]. Therefore, we 
analyzed the relevance of the cysteines of the CX3CXnH motif for the interaction with 
COA6 and consequently for the dynamics of the copper transfer reactions. To this 
end, we generated cysteine mutants of SCO2. SCO2 contains three cysteines (C115, 
C133, and C137), with C133 and C137 being part of the CX3CXnH motif. We generated 
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single mutants changing cysteine to serine residues (SCO2C115S, SCO2C133S, 
SCO2C137S) (Fig. 3B). In order to analyze the effect of the cysteine mutants, we 
generated radiolabelled versions of wild type, SCO2C115S, SCO2C133S, and 
SCO2C137S. SCO2 could be efficiently import into purified wild type mitochondria in a 
membrane potential-dependent manner. Upon import SCO2 was processed to the 
mature form (Fig.3C). Similarly, the mutant versions of SCO2 were efficienctly 
imported into wild type mitochondria (Fig. 3D). To analyze how the cysteine mutants 
in SCO2 affected the interaction with COA6, we performed in vitro import of 
radiolabelled versions of SCO2 into isolated mitochondria from cells expressing C-
terminally FLAG-tagged COA6. After import, COA6 was immunoisolated and bound 
SCO2 detected by autoradiography. Wild type SCO2 (SCO2WT) efficiently co-
precipated with COA6FLAG after in vitro import. SCO2C115S (not being in close 
proximity to the copper coordination center) interacted with COA6FLAG in similar 
amounts as wild type SCO2. Interestingly, the SCO2C133S and SCO2C137S mutants, 
which are affected in the CX3CXnH motif, displayed drastically decreased interactions 
with COA6FLAG by about 80% (Fig. 3E). Thus, the cysteines of the CX3CXnH motif are 
important for SCO2/COA6 interaction. Therefore, we addressed if COA6 and SCO2 
directly interacted through disulphide bridge formation. For this we treated samples 
with Cu2+  as a redox catalysts to oxidize free sulfhydryls and to form disulfide bonds 
between cysteine residues in proximity to each other. After immunoisolation of 
COA6FLAG, we observed specific adducts detected by both SCO2 and FLAG antisera 
(Fig 3 F). 
SCO1 and SCO2 cooperate in the delivery of copper to the cytochrome c 
oxidase subunit COX2 [14]. To analyze if the cysteines in SCO2 determined not only 
the interaction with COA6 but also the dynamics of SCO1 and SCO2, we performed 
in vitro import of radiolabelled versions of SCO2 into mitochondria isolated from cells 
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expressing FLAG-tagged SCO1. Interestingly, the interaction between SCO1 and the 
fully imported, mature SCO2C137S was similar to that of wild type SCO2 (Fig.3G). 
Accordingly, the CX3CXnH motive of SCO2 was not relevant for the SCO1/SCO2 
interaction. Thus, it is tempting to speculate that the SCO1/SCO2 interaction does 
not occur through disulphide bridge formation. However, based on these 
observations, it is likely that a COA6/SCO2 complex forms disulphide bridges during 
the copper transfer cycle.  
 
COA6 acts as a thiol-reductase for copper metallochaperones SCO1 and SCO2 
SCO2 has been shown to reduce cysteines residues in the copper coordination site 
of COX2 in vitro,  whereas it was unable to oxidize cysteines in SCO1, implying that 
other factors are involved in these redox reactions in mitochondria [16]. Our analyses 
showed that the cysteines present in the CX3CXnH motive in SCO2 are determinants 
for the interaction with COA6. Therefore, we considered the possibility that COA6 
might be involved in the regulation of the redox state of the copper 
metallochaperones during CuA biogenesis. To address this, we analyzed the redox 
state of cysteines in SCO2 in COA6KO mitochondria using a maleimide derivate 
coupled to a DNA probe. Upon reaction of the probe with a free cysteine, the target 
protein shows an apparent size shift of approx. 14 kDa in SDS-PAGE analysis. In 
wild type mitochondria SCO2 displayed a molecular weight shift corresponding to 
three free thiol groups. In contrast, in COA6KO mitochondria, SCO2 accumulated in a 
state corresponding to a single reduced cysteine (Fig. 4A). A quantitative 
assessment of the ratio between reduced and oxidized form of SCO2 revealed a 
drastic shift towards the oxidized state in mitochondria lacking COA6. To address if 
the oxidized form of SCO2 in COA6KO mitochondria represented a form with 
disulphide bridge, we pre-incubated COA6KO mitochondria with DTT prior to the 
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maleimide-mediated modification. Upon chemical modification of DTT treated 
COA6KO mitochondria, SCO2 displayed a wild type like migration pattern (Fig. 4A and 
B). To analyze if COA6 contributed to the oxidative state of SCO1 in organello, we 
assessed the availability of free cysteines by maleimide modification analyses in 
mitochondria lacking COA6. While a shifted form of SCO1 that corresponded to two 
free thiol groups was apparent in wild type mitochondria, COA6KO mitochondria 
displayed an accumulation of non-modified SCO1, implying that the two cysteines 
were oxidized. The quantification of the ratio of reduced and oxidized SCO1 showed 
again a drastic decrease of the oxidized state in the absence of COA6 (Fig. 4C). 
Upon treatment of COA6KO mitochondria with DTT, SCO1 could be fully reduced and 
thus be modified by the maleimide (Fig. 4C and D). To support the specificity of the 
observed redox phenotype upon lack of COA6, we expressed a FLAG-tagged 
version of COA6 in COA6KO cells. The redox phenotype of SCO1 and SCO2 in 
COA6KO cells could be rescued by expression of COA6 (Fig. 4E and F), confirming 
that COA6 is required for reduction of the disulphide bridges in both proteins. In 
summary, our findings showed that COA6 is required to reduce a disulphide bridge in 
both SCO1 and SCO2 and that this effect is not indirectly caused by increased ROS 
production or an altered redox state of the intermembrane space.  
 
Discussion 
The catalytic core of the cytochrome c oxidase is conserved from bacteria to human. 
The formation of the binuclear copper center CuA is therefore a common process and 
the particular high reactivity of copper ions necessitates that the copper delivery is 
assisted by copper metallochaperones. However, the mechanisms of CuA biogenesis 
differ between organisms with regard to the participating copper-binding proteins. In 
bacteria, the activity of a periplasmic thioredoxin-like reductase TlpA maintains the 
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active site cysteine pairs of CoxB and ScoI in the reduced state and is thus required 
for Cu2+ binding. The copper chaperone ScoI reacts with apo-CoxB to establish a 
stable Cu2+ containing complex, which is released to form a CoxB-Cu2+ with the aid of 
the chaperone PcuC. A second round of PcuC action delivers Cu+ to CoxB, forming 
the CuA center [24]. In human mitochondria, other players among these COA6 have 
been identified as members of the copper insertion machinery for COX2 [7,8]. 
Interestingly, mammalian mitochondria lack a TlpA homolog. Therefore, the required 
thiol-reductase activity has to be a function of either SCO1, SCO2, or COA6. Our 
findings suggest that COA6 shows a thiol-reductase activity and is involved in the 
reduction of cysteines in the CX3CXnH motif of SCO1 and SCO2. Whereas SCO1 
has been shown to transfer copper to COX2 in vitro in a two-step reaction, SCO2 
presented a thiol-reductase activity that was able to reduce cysteinyl sulfurs of COX2 
in a copper bound state [16]. Based on these observations, we propose that COA6 
recycles SCO2 cysteines into a redox-active form, enabling further rounds of COX2 
cysteinyl sulfur reduction. Remarkably, SCO2 reduced thiol groups of Apo-COX2 at a 
2:1 stoichiometry in vitro [16]. Since COA6 cooperates with SCO2 during COX2 
metallation, it is plausible that in vivo COA6 and SCO2 each provide one reducing 
equivalent per one COX2 molecule. Indeed, the redox potential of yeast COA6 (-
349±1mV) [19] indicated that COA6 could reduce the disulphide bonds in COX2 (-
288±3mV) [16], SCO2 (less than -300mV) [25] or SCO1 (-277±3mV) [26]. However, 
the ability of COA6 to reduce thiol groups of COX2 in vivo could not be addressed in 
our model system, since cells lacking COA6 lack detectable levels of COX2. In 
addition, our analysis suggests that COA6 is involved in SCO1 reduction. In vitro, 
SCO1 can receive copper atoms from COX17 independently of the redox state of its 
cysteine. Whereas SCO2 necessarily needs to be in a reduced state to receive 
copper, SCO1 can be either in a reduced state or it can  be in an oxidized state, 
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being reduced by  COX17 in a simultaneous step with copper transfer [27]. However, 
it is also conceivable that prior to copper transfer by COX17, SCO1 may be reduced 
by COA6. During revision of this manuscript, Soma et al solved the structure of 
human COA6 and showed in in vitro analyses that COA6 was able to reduce 
cysteine residues in purified SCO1, SCO2, and COX2. These results, support our 
analyses of COA6 acting as a thiol-reductase in vivo. However, using COA6 patient-
derived cells, they could only observed effects on cysteine oxidation of SCO1 but not 
SCO2. Differences in the cellular models used for investigation may account for this 
difference with our analyses and need to be further studied in the future [28].  
In conclusion, our results provide insights into the mechanistics of CuA 
biogenesis and defines the function of COA6 as a thiol-reductase for copper 
metallochaperones. In addition, we demonstrate that the loss of COA6 not only 
affects complex IV assembly but also the formation of respiratory chain complex I. 
Remarkably, only one of the patients described with COA6 mutations showed a 
decreased complex I activity [11] [12]. The COA6 knock out mutant used here 
displays reduced complex I and IV activity. However, at this point the question as to 
how a loss of COA6 affects complex I remains open as no link between copper 
chaperone activity and complex I biogenesis has been observed.  
Our analyses indicate that that loss of OXPHOS activity and the concomitant 
reduction of the membrane potential indirectly influences the mitochondrial proteome 
through protein import defects. Interestingly, the ∆ψ-independent import of substrates 
along the MIA40 pathway was not decreased but rather increased in the absence of 
COA6. Upregulation of mitochondrial import pathways has been frequently shown 
when one import pathway is defective [29-31]. However, the molecular reason behind 
this phenomenon remains unclear. In addition, other additional mechanisms apart 
from reduced membrane potential may contribute to the altered mitochondrial 
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proteome in COA6KO cells. For instance, alteration of copper homeostasis drastically 
alters the Fe/S cluster formation that involves the mitochondrial ISCA1/2 and GLRX5 
proteins [32]. Interestingly, the protein levels of ISCA2 and to lesser extent those of 
GLRX5 are decreased in the absence of COA6 (see Sup table 1). Thus, it is 
conceivable that impaired iron-sulfur cluster biogenesis affects may impact the 
steady state levels of different mitochondrial protein and thereby cause alterations in 
protein abundance in many mitochondrial functions in addition to the respiratory 
chain e.g. citric cycle, heme biosynthesis, lipoic acid synthesis. Accordingly, COA6 
dysfunction, e.g. in COA6 patients, leads to pleiotropic defects in mitochondrial 
function.   
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Material and Methods 
 
Cell Culture, Generation of Cell lines and Proliferation Assay. 
HEK293T Flp-In™ T-REX™ or HEK293 were cultured in DMEM media, 
supplemented with 10% (v/v) FBS, 2 mM L-glutamine, 1 mM sodium pyruvate and 
50 µg/mL uridine at 37 °C under a 5% CO2 humidified atm osphere. The COA6KO 
HEK293T cell line was generated using CRISPR-Cas9 genome editing as previously 
described [33]. Briefly, specific sgRNA were designed to target all isoforms of COA6. 
Oligonucleotides were then annealed and ligated into the pX458 vector, which 
contains GFP. Cells were transfected and sorted into single wells of a 96-well plate. 
Clones were screened for the absence of COA6 by immunoblotting. 1 clone was 
used for further analysis and sequencing after genomic DNA isolation confirmed 
disruption of the COA6 gene. Rescue cell line expressing C-terminally tagged 
generated using HEK293T Flp-In™ T-REX™ as previously described [18] . Cell lines 
stable expressing C-terminally FLAG tagged versions of COA6 and  SCO2  were 
generated using  HEK293T Flp-In™ T-REX™ during previous studies[7]. C-terminally 
FLAG tagged SCO1 was generated amplifying SCO1 (NM_004589.4) from cDNA 
and incorporating FLAG sequence in the reverse primer. Amplicon was cloned into 
pcDNA5/FRT/TO vector and HEK293T Flp-In™ T-REX™cells were transfected and 
selected as previously described [34]. For SILAC analysis, cells were grown for five 
passages on DMEM medium lacking arginine and lysine, supplemented with 10% 
(v/v) dialyzed fetal bovine serum, 600 mg/l proline, 42 mg/l arginine hydrochloride 
(13C6,15N4-arginine in ‘heavy’ media), and 146 mg/l lysine hydrochloride (13C6, 15N2-
lysine in ‘heavy’ media) (Cambridge Isotope Laboratories, Tewksbury, MA, USA). 
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Cell proliferation experiments were performed by seeding 250000 cells in 6 
well-plates. After 72h hours, cells were recovered in PBS and counted using an 
automated cell counter CountessTM (Invitrogen). 
 
Real-time respirometry 
Oxygen consumption rate (OCR) was measured with a XF96 Extracellular Flux 
Analyzer (Seahorse Bioscience, Billerica, MA, USA). HEK293T cells were seeded 
the day of the measurement at a density of 40.000 cells/well. Baseline respiration 
was measured in DMEM supplemented with 1 mM pyruvate and 25 mM galactose 
after calibration at 37 °C in an incubator without CO2. Periodic measurements of 
oxygen consumption were performed and OCR was calculated from the slope of 
change in oxygen concentration over time. Metabolic states were measured after 
subsequent addition of 3 µM oligomycin, 1 µM carbonyl cyanide 4 
(trifluoromethoxy)phenylhydrazone (FCCP), 1 µM antimycin A, and 2 µM rotenone. 
 
Enzymatic activities  
A quantitative method (ELISA) for cytochrome c oxidase (CIV) specific activity and 
quantity of complex determinations (Abcam) was applied using manufacturer’s 
instructions as previously described [35]. The lack of a negative slope due to 
Cytochrome c oxidation was consider as a complete lack of cytochrome c oxidase 
activity and set to 0. In the same way, Complex I activity measurements were 
performed according to manufacturer’s instructions (Abcam), as previously published 
[7]. 
 
Membrane Potential and ROS measurements. 
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For estimation of membrane-potential of the mitochondria, cells were stained with 
200µM JC-1. The values of the two fluorescence readings gave a ratiometric 
comparison of mitochondrial membrane potential. Further, cells were also stained 
with 3µM MitoSox Red for measuring mitochondrial ROS. In each case, 5x105 cells 
were stained with the respective dyes for 15 min at 37°C, washed twice with 1xPBS 
and then measured by flow cytometry. 
Flow cytometric analyses were carried out using the BD-Canto flow cytometer 
(Becton Dickinson). 10,000 gated events were captured and FACS-Diva software 
was used to compute the numeric data.  
 
Redox potential measurements 
For measuring Glutathione redox potential, WT or COA6KO cells (100,000 - 300,000) 
were seeded on 25 mm round glass coverslips 24 – 48 h before transfection. 
Genetically encoded protein sensors were transfected using Fugene® HD (Promega 
GmbH, Mannheim, Germany) along with 1 µg of plasmid DNA, according to the 
manufacturer’s instructions. Imaging was performed 24 h after transfection. Plasmids 
pLPCX-mito-Grx1-roGFP2 and pLPCX-IMS-Grx1-roGFP2 were kindly provided by 
Dr. Tobias P. Dick, Heidelberg, Germany. 
Imaging was performed 24 h after transfection using an inverted Olympus 
IX83 microscope, equipped with a MT20 Mercury-Xenon light source, CellSense 
Dimension software (Olympus) and a 40 × air objective (UPlanSApo 40x 0.95, 
Olympus). Measurements were performed at room temperature in Ringer’s buffer 
(pH 7.4) containing 145 mM NaCl, 4 MgCl2, 10 mM Glucose, 10 mM HEPES, 2 mM 
MgCl2 and 0.25 mM CaCl2. The exposure time for both fluorescent channels was 
kept constant during the whole experiment. Excitation filters 405/20 and 470/40 were 
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combined with a dualband CFP/YFP emission filter (F58-017). Data are presented as 
background corrected fluorescence ratios of F405 nm / F470 nm. 
 
Mitochondrial Isolation 
Mitochondria used for Western blotting purposes were isolated by differential 
centrifugation as previously described [36]. For import experiments, mitochondria 
were isolated as previously described [37]. Briefly, cells were harvested and 
resuspended in ice‐cold isotonic buffer (10 mM MOPS [pH 7.2], 75 mM mannitol, 
225 mM sucrose, and 1 mM EGTA) supplemented with 2 mg/ml BSA and 2 mM 
PMSF, and subjected to centrifugation at 1,000 × g for 5 min at 4°C. The cell pellet 
was then resuspended in cold hypotonic buffer (10 mM MOPS [pH 7.2], 100 mM 
sucrose, and 1 mM EGTA) and incubated on ice for 5–7 min. The cell suspension 
was homogenized in a Dounce glass homogenizer (Sartorius). Cold hypertonic buffer 
(1.25 M sucrose and 10 mM MOPS [pH 7.2]) was added to the cell homogenate 
(1.1 ml/g of cells). The homogenate was subjected to centrifugation at 1,000 × g for 
10 min at 4°C to pellet the cellular debris. The su pernatant that contained 
mitochondria was then carefully aspirated and centrifuged again. The supernatant 
was then subjected to high‐speed centrifugation at 10,000 × g for 10 min at 4°C to 
pellet mitochondria. The pellet was resuspended in isotonic buffer without BSA and 
quantified using the Bradford assay.  
 
Quantitative mass spectrometry and data analysis 
Mitochondrial fractions isolated from differentially SILAC-labeled cells were mixed in 
a 1:1 ratio. Proteins were precipitated using acetone and resuspended in 8 M 
urea/10 mM ammonium bicarbonate (AmBic). Cysteine residues were reduced and 
alkylated by consecutive incubation with 5 mM tris(2-carboxyethyl)-phosphine/10 mM 
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AmBic (30 min at 37°C) and 55 mM iodoacetamide/10 m M AmBic (45 min at room 
temperature in the dark). Urea concentration was adjusted to a final concentration of 
2 M using 50 mM AmBic and trypsin was added (1/30 protease-to-protein ratio) for 
proteolytic digestion overnight at 37°C. The experi ment was performed in two 
individual replicates. 
Peptide mixtures were analyzed on an Orbitrap Elite mass spectrometer 
coupled to an UltiMate 3000 RSLCnano HPLC system (Thermo Scientific), which 
was equipped with nanoEase™ M/Z Symmetry C18 pre-columns (length, 20 mm; 
inner diameter, 180 µm) for washing and preconcentration of the peptides and a 
nanoEase™ M/Z HSS C18 T3 analytical column (length, 250 mm; inner diameter, 75 
µm; particle size, 1.8 µm; packing density, 100 Å) (Waters) for peptide separation. 
The solvent system for peptide elution consisted of 4% (v/v) dimethyl sulfoxide/0.1% 
(v/v) formic acid (solvent A) and 30% (v/v) acetonitrile/48% (v/v) methanol/4% (v/v) 
dimethyl sulfoxide/0.1% (v/v) formic acid (solvent B). Peptides were eluted by 
applying a gradient of 3 - 60% solvent B in 305 min, 60 - 95% B in 25 min and 5 min 
at 95% B at a flow rate of 300 nl/min.  
The Orbitrap Elite was operated in data-dependent mode. Survey scans 
ranging from m/z 370 - 1700 were acquired in the orbitrap at a resolution of 120,000 
(at m/z 400) with an automatic gain control (AGC) of 1 x 106 ions and a maximum 
injection time (IT) of 200 ms. The 25 most intense multiply charged precursor 
peptides were selected for low energy collision-induced dissociation in the linear ion 
trap applying a normalized collision energy of 35%, an activation q of 0.25, an 
activation time of 10 ms, an AGC of 5 x 103, and a maximum IT of 150 ms. Dynamic 
exclusion of previously fragmented precursor peptides was set to 45 sec.  
Mass spectrometric raw data were processed using MaxQuant/Andromeda 
(version 1.5.5.1; [38,39] and searched against the Uniprot human proteome set 
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including isoforms (downloaded December 2017) using default settings, except that 
the number of unique peptides and ratio counts required for protein identification and 
quantification, respectively, was set to one. Arg10 and Lys8 were selected as heavy 
labels. Carbamidomethylation of cysteine residues was set as fixed modification and 
methionine oxidation and acteylation of protein N-termini were considered variable 
modifications. The option "Requantify" was enabled to allow for the calculation of 
SILAC ratios even if only the isotope-labeled or unlabeled variant of a peptide is 
present in a sample by assigning a peptide intensity for the missing counterpart from 
the background signals in MS spectra at the expected m/z value. Information about 
proteins identified and COA6KO/WT SILAC ratios determined by MaxQuant are 
provided in Supplemental Table S1. Annotations for mitochondrial proteins are 
derived from the 'Integrated Mitochondrial Protein Index' (IMPI), which was 
downloaded from the MitoMiner database (http://mitominer.mrc-mbu.cam.ac.uk; IMPI 
version Q2 2018; [40]. Only entries for known mitochondrial proteins were 
considered. Information about components of complex I, IV and V (F1Fo ATP 
synthase) are derived from the Human Genome Organisation (HUGO) Gene 
Nomenclature Committee (HGNC; https://www.genenames.org/; [41] 
   
Radioactive precursor synthesis and in organello import 
Radiolabeled precursor proteins were synthesized using rabbit reticulocyte lysate 
(Promega) in the presence of [35S] methionine. The import of radiolabeled 
precursors into isolated mitochondria was performed at 30°C in import buffer 
(250 mM sucrose, 80 mM potassium acetate, 5 mM magnesium acetate, 5 mM 
methionine, 10 mM sodium succinate, 5 mM adenosine triphosphate, and 20 mM 
HEPES/KOH [pH 7.4]). For TIM22 substrates, import buffer was supplemented with 
supplemented with 2 mM ATP, 1 mM DTT, 5 mM creatine phosphate and 0.1 mg/mL 
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creatine kinase. 2% Lysate was used for TIM23 and MIA40 proteins, whereas 10% was 
used for TIM22 imported carrier proteins. Samples were incubated with radiolabelled 
precursors for different times. Import of TIM23 and TIM22 substrates was stopped by 
the dissipation of membrane potential on ice using 8mM antimycin A, 1 mM 
valinomycin and 10 mM oligomycin. MIA40 import was stopped by addition of 50 mM 
IAA and incubation on ice. Non-imported proteins were removed by proteinase K 
(20µg/mL) treatment for 10 min on ice. PMSF (2 mM) was added to inactivate 
proteinase K for 10 min on ice. Mitochondria were collected, washed with SEM buffer 
(250 mM sucrose, 1 mMEDTA, 20 mM Mops [pH 7.2]) and used for SDS-PAGE 
analyses or BN-PAGE analyses. Results were visualized using digital 
autoradiography. Quantifications were performed using ImageQuantTL (GE 
Healthcare) using rolling ball background subtraction. 
 
BN PAGE analyses  
Mitochondria were solubilized in buffer containing 1% digitonin (20 mM Tris/HCl [pH 
7.4], 0.1 mM EDTA,50 mM NaCl, 10% (w/v) glycerol and 1 mM PMSF) to a final 
concentration of 1 mg/mL for 30 min at 4 °C. Lysate s were cleared by centrifugation 
at 14,000g for 15 min at 4 °C and 10x BN loading dy e was added (5% Coomassie 
brilliant blue G-250,500 mM 6-aminohexanoic acid, and 100 mM Bis-Tris [pH 7.0]). 
Samples were loaded onto 6%–16%polyacrylamide gradient gels and separated as 
described [42]                                                                                                                                                 
Cysteine modification Assay and Crosslinking 
Modification of free thiol groups was performed using the Sulfobiotics Protein Redox 
State Monitoring Kit Plus (Dojinjo) according to manufacturer’s indications with slight 
modifications. In brief, 200 µg mitochondria were solubilised at 10 µg/ µl using 
provided detergent for 30 min at 4°C. After clearin g samples by centrifugation at 
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14,000g for 15 min at 4 °C, they were subjected to Cys modification for 30 min at 
37°C and subsequently separated by SDS-PAGE. Acryla mide gel was irradiated with 
UV-light for 15 min and Western blotting was performed afterwards. In organello 
crosslinking was performed using the sulfhydryl crosslinker BMH at 1mM 
concentration or 1mM CuSO4  in crosslinker buffer (Sorbitol 0.6 M, 20 mM Hepes [pH 
7.2]) for 45 min on ice. Samples were quenched by adding 50 mM Cysteine (for 
BMH) or 10 mM EDTA and N-ethylmaleimide (NEM) (final concentration).  
Mitochondria were re-isolated by centrifugation at 10,000xg 10 min at 4°C and 
subsequently washed with SEM buffer once in the case of BMH crosslinking. 
Afterwards, FLAG immunoisolation and Western blotting under non-reducing 
conditions were performed.  
 
FLAG immunoisolation  
Isolated mitochondria were solubilized in buffer (50 mM Tris-HCl, [pH 7.4], 150 mM 
NaCl, 1 mM EDTA, 10% (w/v) glycerol, and 2 mM phenylmethylsulfonyl fluoride 
[PMSF]) containing 1% (w/v) digitonin (Merck) or 0.2 % triton-x100 (in the case of 
CuSO4 crosslinking) and incubated at 4°C. Samples were c leared by centrifugation, 
and supernatants applied to equilibrated anti-FLAG-agarose (Sigma). After washing, 
bound proteins were eluted with 1.5x Sample Buffer (94 mM Tris-HCl [pH 6.8], 3% 
SDS, 25% glycerol, 0.015% Bromophenol Blue) or FLAG peptide and subjected to 
SDS-PAGE and Western blotting. 
Miscellaneous  
Standard procedures were used for SDS-PAGE and Western blotting of proteins 
adsorbed to polyvinylidene fluoride membranes (Millipore). Primary antibodies were 
raised in rabbit or purchased (COX11, Proteintech. NDUFS1, Proteintech. NDUFS5, 
Abcam. NDUFA8, Abcam. NDUFB7, Abcam. NDUFA5, Proteintech, COX7A2, 
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Proteintech. COX3, Proteintech. ATP5O, Proteintech. ATP5F1, Proteintech.). 
Antigen-antibody complexes were detected by HRP-coupled secondary antibodies 
and enhanced chemiluminescence detection on X-ray films. 
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Figure Legends 
 
Figure 1. Lack of COA6 affects complex I and complex IV 
A. Scheme of COA6 function in copper transfer to CuA center in COX2 (IMS, 
intermembrane space). B Cell were seeded in glucose containing medium to equal 
density and counted after 72h. Cell numbers were calculated and are presented as % 
of wild type (WT) (mean +/– SEM, n= 3). C. Representative real-time respirometry 
analysis of intact cells. Values are presented as mean +/– SEM, n=6. D. Activity of 
complex IV (mOD/min) was measured photometrically; (mean +/– SEM, n= 3). E 
Complex IV amount was measure by ELISA (mean +/– SEM, n= 3). F. Complex I 
activity (mOD/min) was measured photometrically; (mean +/– SEM, n= 3). G. 
Reactive oxygen species in wild type (WT) and COA6 knock out cells (COA6KO) cells 
were assessed by MitoSOX staining and flow cytometry; (mean +/– SEM, n= 3). H. 
Glutathione redox potentials were measured in wild type (WT) and COA6 knock out 
cells upon transfection with either Mito-Grx1-roGFP2 or IMS-Grx1-roGFP2 and 
analyzed by live imaging. Ratio of fluorescence at 405/470 nm is presented as 
average +/– SEM, n>44.  
 
Figure 2. Lacks of COA6 impacts protein import. 
A. Quantitative MS analysis of changes in the mitochondrial proteome in cells lacking 
COA6. B. Purified wild type (WT) and COA6KO mitochondria were analyzed by SDS-
PAGE and Western blotting. C. Mitochondrial membrane potential was measured by 
flow cytometry using the dye JC-1. Fluorescence signals are depicted as mean +/– 
SEM, n= 4. D. In vitro import of radiolabeled precursor proteins into purified wild type 
(WT) and COA6KO mitochondria. Su9-DFHR and OTC were imported for indicated 
times in the presence or the absence of membrane potential (∆ψ). Samples were 
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Proteinase K (PK) treated after import, subjected to SDS-PAGE, and proteins 
visualized by digital autoradiography (p, precursor; m, mature). E. Quantification of 
Su9-DFHR import into mitochondria. Signals were quantified and are presented as 
percent of the longest import timepoint in the wild type (WT) sample, mean, SEM +/– 
SEM, n=3. F. In vitro import of radiolabeled carrier precursors ANT3 (ADP/ATP 
carrier 3) and SLC25A19 (thiamine pyrophosphate carrier) into purified wild type 
(WT) and COA6KO mitochondria. Import was carried out for different times in the 
presence or absence of ∆ψ. After import mitochondria were proteinase K (PK) 
treated, solubilized, and subjected to BN-PAGE separation and digital 
autoradiography. G. Quantification of ANT3 import into mitochondria. Signals were 
quantified and are presented as percent of the longest import timepoint in the wild 
type (WT) sample, mean, SEM +/– SEM, n=3. H. In vitro import of radiolabeled twin 
CXNC motifs containing precursors COX6B1 and COX19 into purified wild type (WT) 
and COA6KO mitochondria. Import was carried out for indicated times in the presence 
or absence of the cysteine modifying agent iodoacetamide (IA). Samples were 
subjected to proteinase K (PK) digested and analyzed by SDS-PAGE and digital 
autoradiography. I. Quantification of COX6B1 import into mitochondria. Signals were 
quantified and are shown as percent of the longest import timepoint in the wild type 
(WT) sample; mean, SEM +/– SEM, n=3. 
 
Figure 3. Cysteines in the CXXXC motif of SCO2 are required for binding to 
COA6 
A. Wild type (WT) and COA6FLAG mitochondria were subjected to chemical 
crosslinking using the homo-bifunctional crosslinker BMH. After crosslinking, 
mitochondria were solubilized and subjected to anti-FLAG immunisolation. Samples 
were analyzed by SDS-PAGE and Western blotting. B. Schematic representation of 
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generated SCO2 mutants. Red, cysteines of the CX3XNH motif; Green, ex-changed 
residue; TM, transmembrane span. C In vitro import of radiolabeled SCO2WT into 
purified wild type mitochondria in presence or the absence of membrane potential 
(∆ψ). Samples were subjected to proteinase K (PK) digest, and analyzed by SDS-
PAGE and digital autoradiography. D. In vitro import of SCO2 cysteine mutants as in 
C. E. After in vitro import of indicated SCO2 variants into purified wild type (WT) and 
COA6FLAG mitochondria, samples were solubilized, subjected to anti FLAG 
immunoisolation, and eluates analyzed by SDS-PAGE, digital autoradiography and 
Western blotting. F. Wild type (WT) and COA6FLAG mitochondria were subjected to 
CuSO4 treatment. After treatment, mitochondria were solubilized and subjected to 
anti-FLAG immunisolation. Samples were analyzed by SDS-PAGE and Western 
blotting. G. SCO1FLAG immunoisolation after in vitro import of SCO2 variants into 
purified wild type (WT) and SCO1FLAG mitochondria. After import of radiolabeled 
SCO2 variants, anti FLAG immunoisolation was performed and eluates analyzed by 
SDS-PAGE and digital autoradiography. 
 
Figure 4. COA6 acts as a thiol-reductase for copper metallochaperones SCO1 
and SCO2 
A. Wild type (WT) and COA6KO mitochondria were incubated in the presence or 
absence of DTT and subjected to cysteine modification. Samples were subjected to 
SDS-PAGE and western blotting. B. Quantification of the ratio between most reduced 
and most oxidized form of SCO2 in wild type (WT) and COA6KO mitochondria 
presented as percent of WT; mean +/– SEM, n=3 C and D. Cysteine redox 
modification assay for SCO1 was carried out as described in A and B. E and F. 
Cysteine redox modification assay for SCO2 and SCO1 in cells expressing 
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COA6FLAG. Wild type (WT) COA6KO and COA6KO+COA6FLAG mitochondria were 
subjected cysteine modification and analyzed by SDS-PAGE and western blotting. 
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• Loss of COA6 affects respiratory chain complexes IV and I. 
• Decreased membrane potential driven protein import due to loss of COA6. 
• Cysteine residues in CX3CXNH motif of SCO2 mediate COA6 interaction. 
• COA6 acts as thiol reductase for copper metallochaperones during CuA biogenesis. 
